Yu Tao Selected Research

CRISPR-Associated Protein 9

1/2021	Coassembly of nucleus-targeting gold nanoclusters with CRISPR/Cas9 for simultaneous bioimaging and therapeutic genome editing.
1/2021	Spatiotemporal control of CRISPR/Cas9 gene editing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Tao Research Topics

Disease

42	Neoplasms (Cancer) 06/2022 - 10/2003
21	Breast Neoplasms (Breast Cancer) 02/2021 - 10/2003
19	Inflammation (Inflammations) 01/2022 - 07/2015
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2005
6	Infections 10/2022 - 04/2010
6	Colitis 08/2022 - 12/2019
6	Neoplasm Metastasis (Metastasis) 06/2022 - 04/2010
6	Triple Negative Breast Neoplasms 02/2021 - 07/2016
5	Carcinogenesis 10/2020 - 04/2009
5	Spontaneous Abortion (Miscarriage) 12/2019 - 01/2013
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2022 - 12/2019
4	Pain (Aches) 01/2022 - 01/2019
4	Hypertension (High Blood Pressure) 11/2021 - 01/2016
4	Carcinoma (Carcinomatosis) 04/2019 - 05/2003
4	Hypersensitivity (Allergy) 02/2019 - 12/2016
3	Wounds and Injuries (Trauma) 01/2022 - 06/2020
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2003
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 12/2019
3	Hypoxia (Hypoxemia) 01/2022 - 01/2011
3	Reperfusion Injury 01/2022 - 11/2018
3	COVID-19 01/2021 - 07/2020
3	Neurofibrosarcoma (MPNST) 07/2020 - 01/2018
3	Experimental Arthritis 11/2019 - 01/2018
3	Endometriosis 01/2017 - 04/2011
3	Hyperplasia 08/2015 - 04/2009
2	Chronic Hepatitis B 10/2022 - 10/2021
2	Liver Diseases (Liver Disease) 10/2022 - 05/2008
2	Residual Neoplasm 06/2022 - 04/2021
2	Hemorrhage 06/2022 - 04/2021
2	Glioma (Gliomas) 05/2022 - 03/2020
2	Acute Lung Injury 01/2022 - 07/2021
2	Hepatitis 12/2021 - 05/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2021 - 11/2020
2	Rectal Neoplasms (Rectal Cancer) 05/2021 - 06/2020
2	Rectal Fistula (Anal Fistula) 05/2021 - 12/2020
2	Communicable Diseases (Infectious Diseases) 01/2021 - 07/2012
2	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2020 - 11/2011
2	Adenocarcinoma of Lung 04/2020 - 01/2009
2	Adenocarcinoma 04/2020 - 01/2009
2	Ulcerative Colitis 01/2020 - 12/2015

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 10/2022 - 05/2003
12	CytokinesIBA 01/2022 - 06/2002
11	Estrogen ReceptorsIBA 01/2020 - 10/2003
10	Biological ProductsIBA 05/2021 - 10/2003
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2005
8	Pharmaceutical PreparationsIBA 06/2022 - 05/2005
6	Messenger RNA (mRNA)IBA 01/2020 - 01/2013
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 06/2002
5	GoldIBA 02/2019 - 05/2013
5	InterleukinsIBA 01/2019 - 10/2013
5	Letrozole (Femara)FDA LinkGeneric 04/2017 - 10/2003
5	Estrogens (Estrogen)FDA Link 07/2009 - 10/2003
4	Dextran SulfateIBA 01/2022 - 01/2020
4	Tamoxifen FDA LinkGeneric 10/2008 - 10/2003
3	arctigeninIBA 08/2022 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022 - 08/2014
3	Fibronectins (Fibronectin)IBA 01/2022 - 04/2019
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
3	VaccinesIBA 12/2021 - 01/2019
3	CollagenIBA 03/2021 - 04/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2005
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2019
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 03/2007
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 10/2013
3	LipopolysaccharidesIBA 01/2020 - 10/2018
3	Fluorescein-5-isothiocyanate (FITC)IBA 02/2019 - 01/2017
3	MicroRNAs (MicroRNA)IBA 01/2018 - 10/2014
3	Peptides (Polypeptides)IBA 01/2018 - 11/2014
3	graphene oxideIBA 07/2016 - 05/2013
3	EnzymesIBA 07/2015 - 04/2011
2	Oxygen (Dioxygen)IBA 06/2022 - 01/2021
2	Glutathione (Reduced Glutathione)IBA 06/2022 - 01/2021
2	TYK2 Kinase (Tyrosine Kinase 2)IBA 01/2022 - 01/2019
2	Interleukin-33IBA 01/2022 - 12/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 10/2020
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2019
2	Antiviral Agents (Antivirals)IBA 10/2021 - 04/2019
2	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2021
2	oxidized low density lipoproteinIBA 09/2021 - 11/2020
2	Triglycerides (Triacylglycerol)IBA 09/2021 - 01/2021
2	LipidsIBA 09/2021 - 11/2020
2	HDL CholesterolIBA 09/2021 - 11/2020
2	LDL CholesterolIBA 09/2021 - 11/2020
2	Biocompatible Materials (Biomaterials)IBA 02/2021 - 01/2021
2	SilverIBA 02/2021 - 01/2021
2	CRISPR-Associated Protein 9IBA 01/2021 - 01/2021
2	AntigensIBA 01/2021 - 01/2019
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 07/2010
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 11/2020
2	CateninsIBA 01/2020 - 01/2011

Therapy/Procedure

40	Therapeutics 10/2022 - 10/2003
9	Drug Therapy (Chemotherapy) 06/2022 - 01/2009
4	Oral Administration 01/2022 - 01/2019
3	Lasers (Laser) 03/2020 - 12/2014
3	Adjuvant Chemotherapy 01/2019 - 10/2008
2	Proctectomy 05/2021 - 06/2020
2	Photothermal Therapy 04/2021 - 08/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2021 - 01/2020
2	Liver Transplantation 01/2021 - 01/2021
2	Mammaplasty (Breast Reconstruction) 01/2020 - 01/2019